Edgewell Personal Care (EPC) FY2017 results: revenue $2.3 billion, down 2.7% on the year
Edgewell Personal Care Co. (EPC) reported revenue of $2.3 billion for fiscal 2017, the year ended 30 September 2017, down 2.7% on the year before. Net income was $6 million, down 96.8%, and diluted earnings per share $0.10. The figures are the company's own, from the 10-K it filed with the SEC on 26 November 2019.
Revenue
$2.3 billion
-2.7% on the year
FY2010FY2017
Operating margin
n/a
FY2010FY2017
Net income
$6 million
-96.8% on the year
FY2010FY2017
Diluted EPS
$0.10
-96.7% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
2,298
2,362
2,421
-2.7%
Cost of revenue
1,172
1,202
1,237
-2.5%
Gross profit
1,126
1,160
1,184
-2.9%
Gross margin
49.0%
49.1%
48.9%
Research and development
67.6
71.9
71.0
-6.0%
Interest expense
69.2
71.8
99.8
-3.6%
Pre-tax income
-52.9
220
-459
Income tax
-58.6
41.2
-163
Effective tax rate
n/a
18.7%
n/a
Net income
5.7
179
-275
-96.8%
Net margin
0.2%
7.6%
-11.4%
Diluted EPS
$0.10
$2.99
-$4.44
-96.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
314
187
149
+67.9%
Capital expenditure
69.0
69.5
99.4
-0.7%
Free cash flow
245
117
49.4
+108.5%
Free cash flow margin
10.6%
5.0%
2.0%
Cash from investing
-84.6
-69.5
-175
Cash from financing
-478
-93.4
-327
Depreciation and amortisation
94.4
92.6
115
+1.9%
Share-based compensation
22.2
25.6
32.9
-13.3%
Buybacks
165
197
175
-15.9%
Dividends paid
0.0
0.0
93.2
Dividend per share
n/a
n/a
$1.50
Diluted shares, weighted
58m
60m
62m
-3.7%
Shares outstanding at period end
56m
58m
60m
-3.3%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
1,742
1,829
1,864
-4.8%
Debt
1,525
1,826
1,722
-16.5%
Other liabilities
922
1,116
1,406
-17.4%
Total liabilities and equity
4,189
4,772
4,992
-12.2%
Fixed assets
453
486
499
-6.7%
Goodwill
1,446
1,420
1,422
+1.8%
Intangible assets
1,072
1,385
1,408
-22.6%
Cash and equivalents
503
739
712
-31.9%
Receivables
224
261
280
-14.0%
Inventory
334
309
333
+7.9%
Other assets
157
171
338
-8.1%
Total assets
4,189
4,772
4,992
-12.2%
10-K for the year ended 30 September 2017, filed 26 November 2019: the filing.